Emotion Focused Internet Delivered Treatment for Adults with Eating Disorders
NCT ID: NCT06885866
Last Updated: 2025-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2022-03-02
2024-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The internet delivered treatment is divided into two phases, phase A and phase B. Phase A focus on establishing normalised eating patterns, and in phase B the emotion regulation interventions are added. Participants will get access to treatment modules every third day over a time period of 8.5 weeks, each module consist of psychopedagogical material, excercises and home work.
Data will be collected via the online research platform every third day during the treatment. Data is also collected at more comprehensive assessment points pre-treatment, post-treatment, and follow up 3 months after end of treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Emotion Regulation Group Skills Training for Eating Disorders
NCT04148014
Prevention of Eating Disorders Through Optimization of Protective Factors
NCT05863598
A Digital Treatment for Adolescents With Eating Disorders
NCT06306586
Virtual Body Project Groups Led by Peers Versus Clinicians
NCT05993728
An ACT Group Intervention for ED-patients
NCT02058121
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The baseline lenght (i.e., phase A) is randomized for each participant. There is six possible assignments, as the randomization is restricted to give all participants minimum 8 and maximum 12 treatment modules in each phase, with minimum 9 and maximum 14 baseline assessment points.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Emotion regulation treatment
Emotion regulation treatment
Emotion regulation intervention in two phases. Phase A focus on establishing normalised eating patterns, and in phase B the emotion regulation interventions are added. Participants will get access to treatment modules every third day over a time period of 8.5 weeks, each module consist of psychopedagogical material, excercises and home work.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Emotion regulation treatment
Emotion regulation intervention in two phases. Phase A focus on establishing normalised eating patterns, and in phase B the emotion regulation interventions are added. Participants will get access to treatment modules every third day over a time period of 8.5 weeks, each module consist of psychopedagogical material, excercises and home work.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimum 18 years old
* Ongoing contact with a psychiatric clinic in sweden
Exclusion Criteria
* Somatic instability due to eating disorder severeness
* High risk of suicide or severe self-harm
* Ongoing addiction or substance abuse
* Ongoing psychological treatment or psychotherapy
* New or changed mediciation for psychiatric disorders in the past 2 months
* Planned or ongoing pregnancy or recently gave birth
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Linkoeping University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hugo Hesser
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hugo Hesser, PhD
Role: PRINCIPAL_INVESTIGATOR
Örebro University, Linköping University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Linköping University
Linköping, Östergötland County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IBL-2021-00215
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.